Trazodone is neither an SSRI nor an SNRI. It belongs to a different class called serotonin antagonists and reuptake inhibitors, or SARIs. While trazodone does affect serotonin like those better-known drug classes, it works through a distinct combination of mechanisms that sets it apart from both.
What Makes Trazodone Different From SSRIs and SNRIs
The confusion is understandable. SSRIs (like sertraline and fluoxetine), SNRIs (like venlafaxine and duloxetine), and trazodone all influence serotonin in the brain. But they do so in meaningfully different ways.
SSRIs work by blocking the reabsorption of serotonin, which keeps more of it available between nerve cells. That’s essentially all they do. SNRIs do the same thing but add a second target: they also block the reabsorption of norepinephrine, another chemical messenger involved in mood and alertness.
Trazodone does something more complex. It blocks serotonin reabsorption like an SSRI, but it simultaneously blocks specific serotonin receptors (called 5-HT2A and 5-HT2C). This dual action, inhibiting reuptake while also antagonizing certain receptors, is why it gets its own class name. Trazodone also blocks a type of adrenaline receptor in blood vessels, which is why it can cause dizziness or lightheadedness when you stand up quickly.
Why the SARI Distinction Matters
This isn’t just a technicality. The way trazodone interacts with serotonin receptors changes its practical effects compared to SSRIs. Its receptor-blocking properties are what make it sedating, which is why it’s prescribed far more often for sleep problems than for depression alone. At lower doses, the sedating effects tend to dominate. At higher doses (150 to 400 mg per day), the serotonin reuptake inhibition becomes more prominent, and it functions more like a traditional antidepressant.
The FDA originally approved trazodone for major depressive disorder, not insomnia. But its sleep-promoting effects made it one of the most commonly prescribed off-label sleep aids in the United States. Many people taking trazodone at bedtime are on doses well below what’s used for depression.
Sexual Side Effects: A Key Difference
One of the biggest practical differences between trazodone and SSRIs is the rate of sexual side effects. SSRIs are well known for dampening desire and making orgasm difficult. In a randomized controlled trial comparing trazodone to fluoxetine and sertraline, trazodone caused significantly less sexual dysfunction. Only 12% to 18% of men on trazodone reported problems with desire, compared to 43% to 51% on fluoxetine. Arousal and orgasm difficulties in men on trazodone ranged from 9% to 15%, while fluoxetine produced much higher rates. Women showed a similar pattern, with trazodone causing the least impairment across the board.
There is, however, one rare but serious sexual side effect unique to trazodone: priapism, a prolonged, painful erection unrelated to arousal. This occurs in fewer than 1 in 1,000 men, with most cases developing within the first month of treatment. It’s a medical emergency because restricted blood flow can cause permanent tissue damage in as little as six hours. More than half of men whose priapism lasts beyond 24 hours develop permanent erectile dysfunction. The risk is low, but it’s something men starting trazodone should be aware of.
How Trazodone Feels Compared to SSRIs
Because of its receptor profile, trazodone tends to produce noticeable drowsiness, especially early in treatment. This is the main reason it’s used for sleep. SSRIs, by contrast, can go either way: some people feel more alert or even jittery, while others feel fatigued. SNRIs, because they also boost norepinephrine, tend to be more activating than sedating.
Trazodone has a relatively short half-life of about 5 to 13 hours, which means it clears your system faster than many SSRIs. This is useful when it’s taken for sleep, since it’s less likely to leave you groggy the next afternoon. But it also means that when used for depression at higher doses, it’s typically taken in divided doses throughout the day rather than once in the morning like most SSRIs.
The dizziness from trazodone’s adrenaline receptor blocking is worth noting. It’s most common when standing up quickly and tends to be worse at higher doses. SSRIs and SNRIs rarely cause this particular problem.
Choosing Between Drug Classes
In practice, trazodone fills a different niche than SSRIs or SNRIs. When depression is the primary concern, SSRIs and SNRIs are typically first-line treatments. Trazodone for depression is usually reserved for cases where those options haven’t worked or aren’t tolerated, often because of sexual side effects.
Where trazodone shines is as a sleep aid, either on its own or alongside an SSRI or SNRI. Because it works on different receptors, it can complement an existing antidepressant without duplicating its mechanism. This combination is common: a person might take an SSRI during the day for depression and a low dose of trazodone at night for sleep.
The bottom line is that trazodone, SSRIs, and SNRIs are three separate drug classes that all happen to involve serotonin. Knowing the distinction helps you understand why trazodone behaves so differently in your body, from its sedating effects to its lower rate of sexual side effects to its blood pressure quirks.